HomeBest options strategy › NBP

Best Options Strategy for NBP

By Dennis Bosmans · Updated 2026 · 2 min read · Risk disclaimer

Looking for the best options strategy for NovaBridge Biosciences (NBP)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live NBP option chain right now, and a simple map from your view on NBP to the strategy that fits it. Model any of them in the calculator before you trade.

About NBP

NovaBridge Biosciences (NBP) is a major company in Biotechnology. Options traders on NBP tend to watch , since these can drive large moves in the share price.

About NovaBridge Biosciences

NovaBridge Biosciences is a biotech company focused on developing immunotherapy drugs, primarily targeting cancer through bispecific antibodies and related biologics. The company operates two main business areas: oncology and ophthalmology. In oncology, its lead program is givastomig, a CLDN18.2-targeting bispecific antibody currently in phase 2 testing for gastric cancer and other gastrointestinal tumors when combined with checkpoint inhibitors and chemotherapy. The pipeline also includes ragistomag, an earlier-stage candidate in phase 1 for solid tumors. On the ophthalmology side, NovaBridge is developing VIS-101, a bispecific biologic targeting VEGF-A and ANG-2 that has reached phase 2 evaluation for wet age-related macular degeneration and diabetic eye conditions.

The company generates revenue through strategic partnerships and licensing agreements rather than commercial drug sales at this stage. It collaborates with major pharmaceutical names including Bristol Myers Squibb on givastomig development, AskGene on VIS-101, and AbbVie on lemzoparlimab, an immunotherapy asset. Founded in 2014 and headquartered in Rockville, Maryland, NovaBridge (formerly known as I-Mab) operates…

Today's top-scoring strategy for NBP

Our engine ranks defined-risk strategies on the live NBP chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.

Long Call Butterfly neutral
Price: $100.00Implied volatility: 32%Expiration: 2026-07-17 (30d)
ActionQtyTypeStrikePremium
BuyCALL$95$6.83
SellCALL$100$3.82
BuyCALL$105$1.87
P/L at expiry vs today At expiry Today ±1σ
$82$100$118
Max Profit
$394
Max Loss
−$106
Net Debit (cost)
$106
Prob. of Profit
33%
Breakeven(s)
$96.06, $103.94
Implied Vol (ATM)
32%
Position Greeks
Δ
0.43
Γ
−1.202
Θ
1.69
ν
−3.16
Time decay (price held)

Simulation

Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.

Win rate
33%
Mean P/L
−$2
Median
−$106
Exp. move (1σ)
9%
5th pct
−$106
25th pct
−$106
75th pct
$96
95th pct
$333
$-100$144$388
Analyze NBP in the calculator → Share this pick ↗

Illustrative example at NBP's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.

Implied volatility

NBP typically trades with moderate implied volatility, broadly in line with other large-cap stocks. Implied volatility drives option prices, so it is worth checking the live chain before you trade.

Earnings & IV crush

NBP's next earnings report is due around July 6, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.

Key figures

Market cap
$247M
Beta (vs market)
1.48
52-week range
$1.46–$6.79
Short interest
6.0% of float · 6.4 days to cover

How to choose an options strategy for NBP

Start with your outlook on NBP, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:

Bullish

You expect NBP to rise

Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.

Long Call → Bull Call Spread →

Bearish

You expect NBP to fall

Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.

Long Put → Bear Put Spread →

Neutral

You expect NBP to trade in a range

Sell an iron condor to collect premium while NBP stays between two strikes, or write a covered call against shares you already own.

Iron Condor → Covered Call →

How we pick the best strategy

For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →

Open NBP in the free calculator →

Frequently asked questions

What is the best options strategy for NBP?

It depends on your outlook. Bullish traders often use a long call or bull call spread on NBP; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.

Are NBP options liquid enough to trade?

NovaBridge Biosciences (NBP) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.

How much money do I need to trade NBP options?

Buying a single NBP call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.

Is this financial advice?

No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade NBP or any security. Do your own research.

What does NovaBridge Biosciences do?

NovaBridge Biosciences (NBP) operates in the Biotechnology industry. The "About NovaBridge Biosciences" section above gives a fuller picture of what the company does and how it earns money.

Does NovaBridge Biosciences pay a dividend?

NovaBridge Biosciences does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.

When does NovaBridge Biosciences next report earnings?

NovaBridge Biosciences's next earnings are expected around July 6, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.

Tickers related to NBP

Comparing NBP with similar names can help you choose the best options strategy:

ZLABZai Lab LimitedLEGNLegend Biotech CorporationZNTLZentalis Pharmaceuticals, Inc.

Company information

Headquarters
2440 Research Boulevard, Suite 400, Rockville, MD, 20850, United States
Industry
Biotechnology
Employees
30
Phone
240 745 6330
Website
novabridge.com

Best Options Strategy by Ticker →

Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.